Drugs / YBL-006
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04450901 | Jul 2020 → Mar 2023 | cancer | Y Biologics Inc. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | YBL-006 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04450901 ↗ |
| Route | Intravenous | “Route of Administration: IV infusion” NCT04450901 ↗ |